Sentences with word «robenacoxib»

«Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis.»
«Population pharmacokinetic analysis of blood and joint fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis.»
To evaluate the toxicity and systemic exposure of robenacoxib tablets when administered to healthy adult dogs that received test article at 0.5, 1.5, and 2.5 times the maximum target exposure based on the inherent dose bands of the tablet sizes.
Onsior contains the active ingredient robenacoxib, an NSAID (non-steroidal anti-inflammatory drug) that targets the COX - 2 enzyme that causes pain.
Pelligand, L., King, J., Toutain, P., et al. 2012 «Pharmacokinetic / pharmacodynamics modelling of robenacoxib in a feline tissue cage model of inflammation.»
A randomized, blinded, placebo - controlled pivotal field study to evaluate the effectiveness and safety of robenacoxib (tablets) when administered at a dose of 2 mg / kg once daily for 3 days for the control of postoperative pain and inflammation associated with soft - tissue surgery in dogs.
Typical medications might include the fentanyl patch, buprenorphine, tramadol, robenacoxib, or others.
Subcutaneous administration of Onsior (robenacoxib) injection at a dose of 2 mg / kg (0.91 mg / lb) once daily for up to 3 days, with the first dose administered approximately 45 minutes prior to surgery, was effective and well - tolerated for the control of postoperative pain and inflammation with soft - tissue surgery in dogs.
Only two nonsteroidal anti-inflammatory drugs are FDA - approved for cats: meloxicam (sold under the brand names METACAM, MELOXICAM, * and LOXICOM *) and robenacoxib (sold under the brand name ONSIOR).
Avoid giving Onisor to pets that have had an allergic reaction to robenacoxib.
The active ingredient in Onsior is robenacoxib.
Giving veterinarians the flexibility to transition a surgical patient from Onsior injection to sending home Onsior ® (robenacoxib) Tablets for Dogs
Do not use in dogs that have a hypersensitivity to robenacoxib or known intolerance to NSAIDs.
Onsior ® (robenacoxib) Tablets for Cats are indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration in cats ≥ 5.5 lbs (2.5 kg) and ≥ 4 months of age; for up to a maximum of 3 days.
Onsior ® (robenacoxib) injection for dogs is indicated for the control of postoperative pain and inflammation associated with soft tissue surgery in dogs ≥ 4 months of age; for up to a maximum of 3 days.
Onsior ® (robenacoxib) injection is indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration in cats ≥ 4 months of age; for up to a maximum of 3 days.
Onsior ® (robenacoxib) Tablets for Dogs are approved for the control of postoperative pain and inflammation associated with soft tissue surgery in dogs ≥ 5.5 lbs (2.5 kg) and ≥ 4 months of age; for up to a maximum of 3 days.
Giving veterinarians the flexibility to transition a surgical patient from Onsior injection to sending home Onsior ® (robenacoxib) Tablets for Cats
Do not use in cats that have hypersensitivity to robenacoxib or known intolerance to NSAIDs.
In the United States, there is one NSAID approved for up to three days use in cats to control pain associated with surgery: ONSIOR (robenacoxib) tablets or ONSIOR (robenacoxib) injection.
a b c d e f g h i j k l m n o p q r s t u v w x y z